The complaint was originally determined to be a malfunction reportable event on 9/4/2019 and reported to the fda through the quarterly voluntary malfunction summary reporting (vmsr) program.Bdpi received a notification from the fda on 9/16/2019 stating that the procode knt is ineligible for the vmsr program; therefore, the mdr date of awareness was modified to reflect the date of the fda notification of procode ineligibility.Manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one ponsky non-balloon gastrostomy tube, one external bolster, one curved hemostat, 2 gauze strips, one packet of lubricating jelly, and one dual port feeding adapte.Visual testing was performed.The obturator was not returned.However, due to the fact that the kit was returned opened and all its components out, the investigation is inconclusive for the alleged missing obturator.A definitive root cause could not be determined based on the available information.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the product labeling is adequate.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|